Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SENSIENT TECHNOLOGIES CORPSXT · Entity 3822 | Director | April 23, 2026 | April 27, 2026 |
| Tonix Pharmaceuticals Holding Corp.TNXP · Entity 6169 | Director | May 06, 2019 | May 08, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SENSIENT TECHNOLOGIES CORP
Report date April 23, 2026 · Filed April 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,447.331 |
Last balance in matching sequence
After 2026-04-23 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-04-23 · Grant · Acquired 1,119 · Balance 11,121.331 F1: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Row 2 · 2026-04-23 · Tax withholding · Disposed 674 · Balance 10,447.331 F3: Shares were withheld to cover tax withholding in connection with the vesting of a prior restricted stock grant. F2: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated.
F2: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
F3: Shares were withheld to cover tax withholding in connection with the vesting of a prior restricted stock grant.
Tonix Pharmaceuticals Holding Corp.
Report date May 06, 2019 · Filed May 08, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.05 · Expires 2029-05-06 | Direct | 30,000 |
Reported balance
After 2019-05-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-05-06 · Grant · Acquired 30,000 · Balance 30,000 F1: The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 23, 2026 Filed Apr 27, 2026 16:52 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 674 | $99.23 | $66,881.02 |
DisclosureSEC source: 0000310142-26-000038 · form4.xml · nonDerivative · entry 2 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,447.331 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of a prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 16:52 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,119 | $0.00 | $0.00 |
DisclosureSEC source: 0000310142-26-000038 · form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,121.331 F1 · kind: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 18:17 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 619 | $80.14 | $49,606.66 |
DisclosureSEC source: 0001127602-25-012672 · form4.xml · nonDerivative · entry 2 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,841.189 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of a prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 18:17 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012672 · form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,460.189 F1 · kind: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 16:02 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 271 | $69.64 | $18,872.44 |
DisclosureSEC source: 0001127602-24-013515 · form4.xml · nonDerivative · entry 2 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,878.917 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of a prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 16:02 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013515 · form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,149.917 F1 · kind: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 27, 2023 Filed May 1, 2023 16:01 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 701 | $73.70 | $51,663.70 |
DisclosureSEC source: 0001127602-23-013854 · form4.xml · nonDerivative · entry 2 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,522.195 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of a prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan and Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 27, 2023 Filed May 1, 2023 16:01 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013854 · form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,223.195 F1 · kind: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan and Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 28, 2022 Filed May 2, 2022 22:15 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 591 | $84.98 | $50,223.18 |
DisclosureSEC source: 0001127602-22-012892 · form4.xml · nonDerivative · entry 2 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,857.083 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of a prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| April 28, 2022 Filed May 2, 2022 22:15 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012892 · form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,448.083 F1 · kind: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:58 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 772 | $81.51 | $62,925.72 |
DisclosureSEC source: 0001127602-21-014452 · form4.xml · nonDerivative · entry 2 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,272.996 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 20:58 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014452 · form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,044.996 F1 · kind: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| April 23, 2020 Filed Apr 24, 2020 20:41 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 612 | $44.10 | $26,989.20 |
DisclosureSEC source: 0001127602-20-014459 · form4.xml · nonDerivative · entry 2 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,793.635 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| April 23, 2020 Filed Apr 24, 2020 20:41 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 2,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014459 · form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,405.635 F1 · kind: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| May 06, 2019 Filed May 8, 2019 11:59 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | GrantStock Option · Derivative | 30,000 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001387131-19-003424 · ownership.xml · derivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-05-06 F1 · price: The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan. F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan. Read SEC document |
| April 25, 2019 Filed Apr 26, 2019 21:13 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 584 | $69.60 | $40,646.40 |
DisclosureSEC source: 0001127602-19-016339 · form4.xml · nonDerivative · entry 2 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,258.272 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| April 25, 2019 Filed Apr 26, 2019 21:13 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016339 · form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,842.272 F1 · kind: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 21:16 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001615774-18-005235 · s110816_form4.xml · derivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-12 F1 · price: The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan. F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan. Read SEC document |
| April 26, 2018 Filed Apr 27, 2018 21:43 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 298 | $67.90 | $20,234.20 |
DisclosureSEC source: 0001127602-18-015460 · form4.xml · nonDerivative · entry 2 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,487.432 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| April 26, 2018 Filed Apr 27, 2018 21:43 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015460 · form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,785.432 F1 · kind: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F1 · price: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 21:00 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0001615774-17-003291 · s106637_form4.xml · derivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-06-20 F1 · price: The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan. Read SEC document |
| May 27, 2017 Filed Mar 9, 2018 20:34 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001752 · s109298_form4.xml · derivative · entry 4 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On May 27, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date. F2 · derivative.expiration_date: On May 27, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date. Read SEC document |
| May 27, 2017 Filed Mar 9, 2018 20:34 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionCommon Stock, $0.001 par value | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001752 · s109298_form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 22:40 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-015908 · form4.xml · nonDerivative · entry 1 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,434.332 F1 · kind: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F1 · price: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| February 09, 2017 Filed Mar 9, 2018 20:34 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001752 · s109298_form4.xml · derivative · entry 5 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On February 9, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date. F3 · derivative.expiration_date: On February 9, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date. Read SEC document |
| February 09, 2017 Filed Mar 9, 2018 20:34 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionCommon Stock, $0.001 par value | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001752 · s109298_form4.xml · nonDerivative · entry 2 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 25, 2016 Filed Mar 9, 2018 20:34 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001752 · s109298_form4.xml · derivative · entry 6 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 600 restricted stock units, vesting in on the first anniversary of the grant date. F4 · derivative.expiration_date: On February 25, 2015, the reporting person was granted 600 restricted stock units, vesting in on the first anniversary of the grant date. Read SEC document |
| February 25, 2016 Filed Mar 9, 2018 20:34 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionCommon Stock, $0.001 par value | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001752 · s109298_form4.xml · nonDerivative · entry 3 LANDRY DONALD W · CIK 0001563616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.